In the BioHarmony Drug Report Database
Mazindol
Mazanor, Sanorex (mazindol) is a small molecule pharmaceutical. Mazindol was first approved as Mazanor on 1982-01-01. It is used to treat duchenne muscular dystrophy and obesity in the USA. The pharmaceutical is active against sodium-dependent dopamine transporter. In addition, it is known to target sodium-dependent noradrenaline transporter.
Trade Name
|
Mazanor, Sanorex |
|---|---|
Common Name
|
mazindol |
ChEMBL ID
|
CHEMBL781 |
Indication
|
duchenne muscular dystrophy, obesity |
Drug Class
|
Image (chem structure or protein)